<code id='B29117C67E'></code><style id='B29117C67E'></style>
    • <acronym id='B29117C67E'></acronym>
      <center id='B29117C67E'><center id='B29117C67E'><tfoot id='B29117C67E'></tfoot></center><abbr id='B29117C67E'><dir id='B29117C67E'><tfoot id='B29117C67E'></tfoot><noframes id='B29117C67E'>

    • <optgroup id='B29117C67E'><strike id='B29117C67E'><sup id='B29117C67E'></sup></strike><code id='B29117C67E'></code></optgroup>
        1. <b id='B29117C67E'><label id='B29117C67E'><select id='B29117C67E'><dt id='B29117C67E'><span id='B29117C67E'></span></dt></select></label></b><u id='B29117C67E'></u>
          <i id='B29117C67E'><strike id='B29117C67E'><tt id='B29117C67E'><pre id='B29117C67E'></pre></tt></strike></i>

          Home / Wikipedia / leisure time

          leisure time


          leisure time

          author:focus    Page View:62
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In